Literature DB >> 8213765

Graft versus host anti-Rho(D) following minor Rh-incompatible orthotopic liver transplantation.

J H Lee1, P D Mintz.   

Abstract

Hemolysis caused by ABO antibodies after ABO-compatible, nonidentical solid organ transplantation has been previously reported. The passenger B lymphocytes within the donor organ presumably generate an acute, primarily red cell-directed graft vs. host (GVH) response. Graft survival may also be compromised. GVH Rh antibodies have also been described, primarily in renal transplants. Only three cases, two only in abstract form, have been reported thus far describing GVH Rh antibodies in liver transplant patients, to which we add a fourth. A 62-year-old blood group A Rho(D)-positive woman with cirrhosis underwent orthotopic liver transplantation from a group A Rho(D)-negative, previously Rho(D)-sensitized donor and subsequently developed acute, self-limited hemolysis requiring four units of packed red cells. Anti-Rho(D) was identified in both serum and red cell eluate. An antibody detection test, identification, and assessment of the antibody reactivity score from the pretransplant donor specimen may identify patients at risk for hemolysis due to GVH Rh antibodies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213765     DOI: 10.1002/ajh.2830440306

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

Review 1.  Passenger lymphocyte syndrome in liver transplant recipients: a description of 12 cases.

Authors:  Samuel Romero; Pilar Solves; Aima Lancharro; Isabel Cano; Federico Moscardó; Nelly Carpio; Miguel Á Sanz
Journal:  Blood Transfus       Date:  2015-04-28       Impact factor: 3.443

Review 2.  Matching donor to recipient in liver transplantation: Relevance in clinical practice.

Authors:  Mettu Srinivas Reddy; Joy Varghese; Jayanthi Venkataraman; Mohamed Rela
Journal:  World J Hepatol       Date:  2013-11-27

Review 3.  Passenger lymphocyte syndrome and liver transplantation.

Authors:  Maxime Audet; Fabrizio Panaro; Tullio Piardi; Ping Huang; Murat Cag; Jacques Cinqualbre; Philippe Wolf
Journal:  Clin Dev Immunol       Date:  2009-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.